Open access · CC-BY
via OpenAlex
The Therapeutic Potential of DNA Damage Repair Pathways and Genomic Stability in Lung Cancer
Joshua T. Burgess, Maddison Rose, Didier Boucher, Jennifer Plowman, Christopher Molloy, Mark A. Fisher, Connor Gerard O’Leary, Derek J. Richard, Kenneth John O'Byrne, Emma Bolderson
Frontiers in Oncology · 2020 · ▲ 55 citations
Abstract
Despite advances in our understanding of the molecular biology of the disease and improved therapeutics, lung cancer remains the most common cause of cancer-related deaths worldwide. Therefore, an unmet need remains for improved treatments, especially in advanced stage disease. Genomic instability is a universal hallmark of all cancers. Many of the most commonly prescribed chemotherapeutics, including platinum-based compounds such as cisplatin, target the characteristic genomic instability of tumors by directly damaging the DNA. Chemotherapies are designed to selectively target rapidly dividing cells, where they cause critical DNA damage and subsequent cell death (1, 2). Despite the initial efficacy of these drugs, the development of chemotherapy resistant tumors remains the primary concern for treatment of all lung cancer patients. The correct functioning of the DNA damage repair machinery is essential to ensure the maintenance of normal cycling cells. Dysregulation of these pathways promotes the accumulation of mutations which increase the potential of malignancy. Following the development of the initial malignancy, the continued disruption of the DNA repair machinery may result in the further progression of metastatic disease. Lung cancer is recognized as one of the most genomically unstable cancers (3). In this review, we present an overview of the DNA damage repair pathways and their contributions to lung cancer disease occurrence and progression. We conclude with an overview of current targeted lung cancer treatments and their evolution toward combination therapies, including chemotherapy with immunotherapies and antibody-drug conjugates and the mechanisms by which they target DNA damage repair pathways.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- DOI
- 10.3389/fonc.2020.01256
- Canonical
- link ↗
- Fetched
- 2026-10-04 MST
Cite this
APA
Burgess, J.T., Rose, M., Boucher, D., Plowman, J., Molloy, C., Fisher, M.A., O’Leary, C.G., Richard, D.J., O'Byrne, K.J., & Bolderson, E. (2020). The Therapeutic Potential of DNA Damage Repair Pathways and Genomic Stability in Lung Cancer. <em>Frontiers in Oncology</em>. https://doi.org/10.3389/fonc.2020.01256
Vancouver
Burgess JT, Rose M, Boucher D, Plowman J, Molloy C, Fisher MA, et al. The Therapeutic Potential of DNA Damage Repair Pathways and Genomic Stability in Lung Cancer. Frontiers in Oncology. 2020. doi:10.3389/fonc.2020.01256.
BibTeX
@article{joshua2020TheThe,
title = {The Therapeutic Potential of DNA Damage Repair Pathways and Genomic Stability in Lung Cancer},
author = {Joshua T. Burgess and Maddison Rose and Didier Boucher and Jennifer Plowman and Christopher Molloy and Mark A. Fisher and Connor Gerard O’Leary and Derek J. Richard and Kenneth John O'Byrne and Emma Bolderson},
journal = {Frontiers in Oncology},
year = {2020},
doi = {10.3389/fonc.2020.01256},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Cancers 2020
Open access · CC-BY
DNA Damage/Repair Management in Cancers
Genetics and Molecular Research 2026
Open access · CC-BY
CHROMOSOMAL INSTABILITY AND DNA REPAIR MECHANISMS IN GENOME INTEGRITY MAINTENANCE
World Journal of Clinical Oncology 2011
Open access · CC-BY
DNA damage and breast cancer
Cells 2021
Open access · CC-BY
Biology before the SOS Response—DNA Damage Mechanisms at Chromosome Fragile Sites
International Journal of Molecular Sciences 2015
Open access · CC-BY
Therapeutic Implications for Overcoming Radiation Resistance in Cancer Therapy
PubMed 2012
Preprint · OA